Michael Thomas Heffernan, Director at Ocata Therapeutics, holds 37.81K shares in Collegium Pharmaceutical (Ticker: COLL), holds 19.37K shares in Biohaven Pharmaceutical Holding Co (Ticker: ~BHVN), holds 34.89K shares in Akebia Therapeutics (Ticker: AKBA).
What is the percentage of profitable transactions made by Michael Thomas Heffernan?
The percentage of profitable transactions made by Michael Thomas Heffernan is 50%.
What is the average return per transaction made by Michael Thomas Heffernan?
The average return per transaction made by Michael Thomas Heffernan is -4.20%.
What stocks does Michael Thomas Heffernan hold?
Michael Thomas Heffernan holds: OCAT, COLL, KERX, AKBA, TRVI, ~BHVN, SYBX, BHVN, ~CRTX stocks.
What was Michael Thomas Heffernan’s latest transaction?
Michael Thomas Heffernan latest transaction was an Uninformative Buy of ―.
What was Michael Thomas Heffernan's most profitable transaction?
Michael Thomas Heffernan’s most profitable transaction was an Informative Sell of COLL stock on June 13, 2018. The return on the trade was 55.60%.
What is Michael Thomas Heffernan's role in Ocata Therapeutics?
Michael Thomas Heffernan's role in Ocata Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.